Frances C. Arrillaga Alumni Center | Stanford, CA

SDDS 2026: Stanford Drug Discovery Symposium

Welcome to the 10th annual Stanford Drug Discovery Symposium, which will be held at the Arrillaga Alumni Center on the Stanford University campus. This milestone year marks a decade of bringing together all members of the drug discovery community, including researchers, pharmaceutical companies, investment groups, and the broader biomedical community. Over two days, attendees will experience a dynamic program with cutting-edge talks, robust panel discussions, an outstanding poster session showcasing innovative research, and a platform for networking. We look forward to welcoming you to the 10th annual SDDS, and to meaningful conversations and new collaborations that emerge from this year’s event.

— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
 

Registration now open!

     

Ticket Registration

Early Bird ticket pricing ends February 28, 2026

Poster Registration

Poster registration deadline: April 10, 2026     

Interested in sponsoring SDDS 2026? Contact us!

Lifetime Achievement Awardees

Carl June, MD

Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine, University of Pennsylvania

Steven Rosenberg, MD, PhD

Chief, Surgery Branch, Center for Cancer Research, National Cancer Institute, NIH

Michel Sadelain, MD, PhD

Herbert and Florence Irving Professor of Medicine, Columbia University

Lifetime Philanthropy Awardees

Joan and Sandy Weill 

Participants

Anthony Adamis, MD

Co-Founder, Director, CSO, EyeBio, a Merck Company

Carolyn Bertozzi, PhD

Nobel Laureate 2022
Baker Family Director of Sarafan ChEM-H

Robert Bradway, MBA

Chairman and CEO, Amgen

Sonia Gupta, MBA

Partner, Co-Head of Biopharma Investment Banking, Goldman Sachs

Sandra Horning, MD

Board Member, Gilead; Board Member, Moderna

Nicole Kleinstreuer, PhD

NIH Deputy Director of Program Coordination, Planning, and Strategic Initiatives

Jerry Lee, MBA

Global Chair of Investment Banking, JP Morgan Chase

Flavius Martin, MD

Executive Vice President, Research,  Gilead

Vijay Pande, PhD

Co-Founder and Managing Partner, VZVC

Michael Quigley, PhD

CSO and Global Head of Research, Sanofi

Randy Schekman, PhD

Nobel Laureate, 2013; Professor of Molecular and Cell Biology, University of California, Berkeley

Michelle Tarver, MD, PhD

Director, Center for Devices and Radiological Health, FDA

Karen Akinsanya, PhD

President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships, Schrödinger

Chris Boshoff, MD, PhD

CSO and President, R&D, Pfizer

Jonathan Cohen

Vice President of Applied Research, NVIDIA

Alistair Henry, PhD

Executive Vice President & CSO, UCB

Thomas Hudson, MD

Venture Partner, Versant Ventures

Brian Kobilka, MD

Nobel Laureate 2012; Helene Irwin Fagan Chair of Cardiology, Stanford University

Jonathan Levin, PhD, MPhil

President and Bing Presidential Professor, Stanford University

Lloyd Minor, MD

Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine

Robert Plenge, MD, PhD

Executive Vice President, Chief Research Officer, Bristol Myers Squibb

John Reed, MD, PhD

Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson

Amit Sinha, MBA

Partner, CIO and Global Head of Life Sciences Investing, Goldman Sachs

Eric Tokat

Co-President of Investment Banking and Partner, Centerview Partners

David Baker, PhD

2024 Nobel Laureate; Henrietta and Aubrey Davis Endowed Prof of Biochemistry, Univ of Washington School of Medicine

James Bradner, MD

Executive Vice President of Research & Development, Amgen

Kenneth Custer, PhD

Exec Vice President and President, Lilly Cardiometabolic Health, Eli Lilly and Company

Tracy Beth Høeg, MD, PhD

Acting Director, Center for Drug Evaluation and Research, FDA

Joe Jimenez, MBA

Co-Founder and Managing Director, Aditum Bio

Roger Kornberg, PhD

Nobel Laureate 2006; Mrs. George A. Winzer Professor of Medicine, Stanford University

Ashley Magargee, MBA

CEO, Genentech

Brett Monia, PhD

CEO, Ionis

Andrew Plump, MD, PhD

President of Research and Development, Takeda

Aviv Regev, PhD, Msc

Head, Executive Vice President, Genentech Research and Early Development

Thomas Südhof, MD

Nobel Laureate 2013; Avram Goldstein Professor and Prof of Neurosurgery, Stanford University

Agenda

TBA

Event Program & Poster

The program will run from 9 am - 6 pm PT on both days, April 27-28, 2026. Please check back for updated information on the full agenda. 

Event Poster

FAQs

Foundation Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Media Partners

Corporate Poster Session

  • | CAS, a Division of the American Chemical Society | Coeurative | Cytiva | EvoQuant | Far Eastern Memorial Hospital | Fuwai Hospital |

    | Greenstone Biosciences | Institute of Biomedical Sciences, Taiwan | ISSCR | Rasayan AI | National Taiwan University | Nomic Bio | 

    | NSTC | Sanyou Biopharmaceuticals | Sophion | Standard BioTools | STEMCELL Technologies | Typhoon Pharma |

    | Varda Space Industries | Vazyme Biotechnology | WuXi AppTec |

 

 

 

Interested in sponsoring SDDS 2026? Contact us today!

Official Sponsor T-Shirt

Showcasing Your Support

Organizers

Amanda Chase, PhD

Associate Director of Strategic Research Development
Stanford Cardiovascular Institute

Kuldev Singh, MD

Professor of Ophthalmology
Stanford University School of Medicine

Sanjay Malhotra, PhD

Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU

Joseph Wu, MD, PhD

Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine

Mark Mercola, PhD

Professor of Medicine
Stanford University School of Medicine
 

Francesca Mae G. Tongco, MS-HCA

Project Coordinator
Stanford Cardiovascular Institute


For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.